Alphavirus neoantigen vectors
US11419929B2 · kind B2 · utility
0Cited by
102References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2018 |
| Grant date | Aug 23, 2022 |
| Priority date | — |
| Expiry date | May 8, 2038 |
Classification
- Technology area (CPC —)General
Abstract
Disclosed herein are alphavirus vectors that include neoantigen-encoding nucleic acid sequences derived from a tumor of a subject. Also disclosed are nucleotides, cells, and methods associated with the vectors including their use as vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.